{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:06:27Z","timestamp":1789632387857,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41401-026-01873-y","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:11:04Z","timestamp":1783494664000},"page":"3069-3082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting USP8 with odoroside A regulates LXR\u03b2-mediated fatty acid metabolic reprogramming against colorectal cancer"],"prefix":"10.1038","volume":"47","author":[{"given":"Yan-yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-han","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-han","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-cao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-bei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"1873_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325:669\u201385.","journal-title":"JAMA"},{"key":"1873_CR3","doi-asserted-by":"publisher","first-page":"e194489","DOI":"10.1001\/jamaoncol.2019.4489","volume":"6","author":"MB Sonbol","year":"2020","unstructured":"Sonbol MB, Mountjoy LJ, Firwana B, Liu AJ, Almader-Douglas D, Mody K, et al. The role of maintenance strategies in metastatic colorectal cancer: a systematic review and network meta-analysis of randomized clinical trials. JAMA Oncol. 2020;6:e194489.","journal-title":"JAMA Oncol"},{"key":"1873_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S2468-1253(23)00146-2","volume":"8","author":"M Loft","year":"2023","unstructured":"Loft M, To YH, Gibbs P, Tie J. Clinical application of circulating tumour DNA in colorectal cancer. Lancet Gastroenterol Hepatol. 2023;8:837\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1873_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","volume":"33","author":"LE Pope","year":"2023","unstructured":"Pope LE, Dixon SJ. Regulation of ferroptosis by lipid metabolism. Trends Cell Biol. 2023;33:1077\u201387.","journal-title":"Trends Cell Biol"},{"key":"1873_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105024","volume":"101","author":"R Harewood","year":"2024","unstructured":"Harewood R, Rothwell JA, Be\u0161evi\u0107 J, Viallon V, Achaintre D, Gicquiau A, et al. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EbioMedicine. 2024;101:105024.","journal-title":"EbioMedicine"},{"key":"1873_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105644","volume":"169","author":"C Jiang","year":"2021","unstructured":"Jiang C, Liu Y, Wen S, Xu C, Gu L. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma. Pharmacol Res. 2021;169:105644.","journal-title":"Pharmacol Res"},{"key":"1873_CR8","doi-asserted-by":"publisher","first-page":"e602","DOI":"10.1093\/nutrit\/nuae046","volume":"83","author":"A Gonz\u00e1lez","year":"2024","unstructured":"Gonz\u00e1lez A, Fullaondo A, Rodr\u00edguez J, Tirnauca C, Odriozola I, Odriozola A. Conjugated linoleic acid metabolite impact in colorectal cancer: a potential microbiome-based precision nutrition approach. Nutr Rev. 2024;83:e602\u2013e614.","journal-title":"Nutr Rev"},{"key":"1873_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ccell.2024.07.005","volume":"42","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang X, Hang D, Lau HCH, Du J, Liu C, et al. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers. Cancer Cell. 2024;42:1386\u2013400.e8.","journal-title":"Cancer Cell"},{"key":"1873_CR10","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/nu12092751","volume":"12","author":"S D\u2019Angelo","year":"2020","unstructured":"D\u2019Angelo S, Motti ML, Meccariello R. \u03c9-3 and \u03c9-6 polyunsaturated fatty acids, obesity and cancer. Nutrients. 2020;12:2751.","journal-title":"Nutrients"},{"key":"1873_CR11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/nu16071040","volume":"16","author":"YM Yu","year":"2024","unstructured":"Yu YM, Li GF, Ren YL, Xu XY, Xu ZH, Geng Y, et al. A free amino acid diet alleviates colorectal tumorigenesis through modulating gut microbiota and metabolites. Nutrients. 2024;16:1040.","journal-title":"Nutrients"},{"key":"1873_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/md21020080","volume":"21","author":"Y Su","year":"2023","unstructured":"Su Y, Choi HS, Choi JH, Kim HS, Jang YS, Seo JW. 7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic acid overcomes chemoresistance of 5-fluorouracil by suppressing the infiltration of tumor-associated macrophages and inhibiting the activation of cancer stem cells in a colorectal cancer xenograft model. Mar Drugs. 2023;21:80.","journal-title":"Mar Drugs"},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10555-018-9744-y","volume":"37","author":"M Volpato","year":"2018","unstructured":"Volpato M, Hull MA. Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer. Cancer Metastasis Rev. 2018;37:545\u201355.","journal-title":"Cancer Metastasis Rev"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41392-023-01405-8","volume":"8","author":"W Wei","year":"2023","unstructured":"Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y, et al. FBXW7\u03b2 loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduct Target Ther. 2023;8:187.","journal-title":"Signal Transduct Target Ther"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41420-024-02126-9","volume":"10","author":"B Li","year":"2024","unstructured":"Li B, Mi J, Yuan Q. Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism. Cell Death Discov. 2024;10:350.","journal-title":"Cell Death Discov"},{"key":"1873_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2221653120","volume":"120","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang F, Lin X, Li Q, Lu Y, Zhang J, et al. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Proc Natl Acad Sci USA. 2023;120:e2221653120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","volume":"14","author":"B Wang","year":"2018","unstructured":"Wang B, Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol. 2018;14:452\u201363.","journal-title":"Nat Rev Endocrinol"},{"key":"1873_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1194\/jlr.M072447","volume":"58","author":"S Bedi","year":"2017","unstructured":"Bedi S, Hines GV, Lozada-Fernandez VV, de Jesus Piva C, Kaliappan A, Rider SD, et al. Fatty acid binding profile of the liver X receptor \u03b1. J Lipid Res. 2017;58:393\u2013402.","journal-title":"J Lipid Res"},{"key":"1873_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100933","volume":"78","author":"E Piccinin","year":"2021","unstructured":"Piccinin E, Cariello M, Moschetta A. Lipid metabolism in colon cancer: role of liver X receptor (LXR) and stearoyl-CoA desaturase 1 (SCD1). Mol Aspects Med. 2021;78:100933.","journal-title":"Mol Aspects Med"},{"key":"1873_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s44324-024-00013-6","volume":"2","author":"MB Antwi","year":"2024","unstructured":"Antwi MB, Jennings A, Lefere S, Clarisse D, Geerts A, Devisscher L, et al. Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease. NPJ Metab Health Dis. 2024;2:13.","journal-title":"NPJ Metab Health Dis"},{"key":"1873_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1654-6","volume":"10","author":"G Wu","year":"2019","unstructured":"Wu G, Wang Q, Xu Y, Li J, Zhang H, Qi G, et al. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?. Cell Death Dis. 2019;10:416.","journal-title":"Cell Death Dis"},{"key":"1873_CR22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200\u201316.","journal-title":"Nat Rev Drug Discov"},{"key":"1873_CR23","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.3390\/ijms19113350","volume":"19","author":"YS Ko","year":"2018","unstructured":"Ko YS, Rugira T, Jin H, Park SW, Kim HJ. Oleandrin and its derivative odoroside A, both cardiac glycosides, exhibit anticancer effects by inhibiting invasion via suppressing the STAT-3 signaling pathway. Int J Mol Sci. 2018;19:3350.","journal-title":"Int J Mol Sci"},{"key":"1873_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.bcp.2009.06.027","volume":"78","author":"Y Takada","year":"2009","unstructured":"Takada Y, Matsuo K, Ogura H, Bai L, Toki A, Wang L, et al. Odoroside A and ouabain inhibit Na+\/K+-ATPase and prevent NF-kappaB-inducible protein expression by blocking Na+-dependent amino acid transport. Biochem Pharmacol. 2009;78:1157\u201366.","journal-title":"Biochem Pharmacol"},{"key":"1873_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201900092","volume":"19","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wen S, Deng C, Yin X, Sun Z, Jiang M, et al. Proteomic analysis reveals that odoroside A triggers G2\/M arrest and apoptosis in colorectal carcinoma through ROS\u2013p53 pathway. Proteomics. 2019;19:e1900092.","journal-title":"Proteomics"},{"key":"1873_CR26","doi-asserted-by":"crossref","unstructured":"Zhang G, Lv S, Bao S, Zhao W, Yi Y, Gao H, et al. Pharmacological mechanisms of natural products with antidepressant effects: A focus on the programmed cell death regulation. J Pharm Anal. 2026;16:101356.","DOI":"10.1016\/j.jpha.2025.101356"},{"key":"1873_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chembiol.2023.02.003","volume":"30","author":"C Lv","year":"2023","unstructured":"Lv C, Huang Y, Wang Q, Wang C, Hu H, Zhang H, et al. Ainsliadimer A induces ROS-mediated apoptosis in colorectal cancer cells via directly targeting peroxiredoxin 1 and 2. Cell Chem Biol. 2023;30:295\u2013307.","journal-title":"Cell Chem Biol"},{"key":"1873_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.trecan.2024.01.008","volume":"10","author":"N Tjader","year":"2024","unstructured":"Tjader N, Toland A. Immunotherapy for colorectal cancer: insight from inherited genetics. Trends Cancer. 2024;10:444\u201356.","journal-title":"Trends Cancer"},{"key":"1873_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci (Weinh). 2023;10:e2302953.","journal-title":"Adv Sci (Weinh)"},{"key":"1873_CR30","first-page":"230","volume":"14","author":"L Liu","year":"2023","unstructured":"Liu L, Zheng B, Luo M, Du J, Yang F, Huang C, et al. Suppression of USP8 sensitizes cells to ferroptosis via SQSTM1\/p62-mediated ferritinophagy. Protein Cell. 2023;14:230\u20134.","journal-title":"Protein Cell"},{"key":"1873_CR31","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ejhf.2141","volume":"23","author":"R Turgeon","year":"2021","unstructured":"Turgeon R, Barry A, Hawkins N, Ellis UM. Pharmacotherapy for heart failure with reduced ejection fraction and health-related quality of life: a systematic review and meta-analysis. Eur J Heart Fail. 2021;23:578\u201389.","journal-title":"Eur J Heart Fail"},{"key":"1873_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jacc.2021.10.037","volume":"79","author":"A Volgman","year":"2022","unstructured":"Volgman A, Nair G, Lyubarova R, Merchant F, Mason P, Curtis A, et al. Management of atrial fibrillation in patients 75 years and older: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79:166\u201379.","journal-title":"J Am Coll Cardiol"},{"key":"1873_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101005","volume":"71","author":"W Zhang","year":"2023","unstructured":"Zhang W, Fan Y, Zhang J, Shi D, Yuan J, Ashrafizadeh M, et al. Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. Drug Resist Updat. 2023;71:101005.","journal-title":"Drug Resist Updat"},{"key":"1873_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118980","volume":"575","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhu Y, Sun C, Xie Y, Adu-Frimpong M, Deng W, et al. GSH responsive nanomedicines self-assembled from small molecule prodrug alleviate the toxicity of cardiac glycosides as potent cancer drugs. Int J Pharm. 2020;575:118980.","journal-title":"Int J Pharm"},{"key":"1873_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51025-1","volume":"15","author":"V Stary","year":"2024","unstructured":"Stary V, Pandey RV, List J, Kleissl L, Deckert F, Kabiljo J, et al. Dysfunctional tumor-infiltrating V\u03b41\u2009+\u2009T lymphocytes in microsatellite-stable colorectal cancer. Nat Commun. 2024;15:6949.","journal-title":"Nat Commun"},{"key":"1873_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2025.156273","volume":"169","author":"Y Lu","year":"2025","unstructured":"Lu Y, Chen L, Lin Y, Zhang Y, Wang Y, Yu W, et al. Fatty acid metabolism: the crossroads in intestinal homeostasis and tumor. Metabolism. 2025;169:156273.","journal-title":"Metabolism"},{"key":"1873_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s10456-024-09938-4","volume":"27","author":"B Pang","year":"2024","unstructured":"Pang B, Dong G, Pang T, Sun X, Liu X, Nie Y, et al. Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction. Angiogenesis. 2024;27:623\u201339.","journal-title":"Angiogenesis"},{"key":"1873_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s11658-024-00536-2","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Yu J, Li R, Zhou H, Chang X. New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cell Mol Biol Lett. 2024;29:21.","journal-title":"Cell Mol Biol Lett"},{"key":"1873_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-01050-5","volume":"19","author":"G Wu","year":"2024","unstructured":"Wu G, Ying L, Zhang Q, Xiong H, Wang J, Chen S, et al. Lipid droplet formation induced by icaritin derivative IC2 promotes a combination strategy for cancer therapy. Chin Med. 2024;19:178.","journal-title":"Chin Med"},{"key":"1873_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41420-023-01493-z","volume":"9","author":"Y Jin","year":"2023","unstructured":"Jin Y, Tan Y, Wu J, Ren Z. Lipid droplets: a cellular organelle vital in cancer cells. Cell Death Discov. 2023;9:254.","journal-title":"Cell Death Discov"},{"key":"1873_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07244-x","volume":"15","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Sun J, Luo Z, Li Y, Huang Y. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death Dis. 2024;15:859.","journal-title":"Cell Death Dis"},{"key":"1873_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2015.05.007","volume":"28","author":"CA Flaveny","year":"2015","unstructured":"Flaveny CA, Griffett K, El-Gendy BE-DM, Kazantzis M, Sengupta M, Amelio AL, et al. Broad anti-tumor activity of a small molecule that selectively targets the warburg effect and lipogenesis. Cancer Cell. 2015;28:42\u201356.","journal-title":"Cancer Cell"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","volume":"13","author":"C Hong","year":"2014","unstructured":"Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014;13:433\u201344.","journal-title":"Nat Rev Drug Discov"},{"key":"1873_CR44","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.3390\/ijms20153787","volume":"20","author":"A Jalil","year":"2019","unstructured":"Jalil A, Bourgeois T, M\u00e9n\u00e9gaut L, Lagrost L, Thomas C, Masson D. Revisiting the role of LXRs in PUFA metabolism and phospholipid homeostasis. Int J Mol Sci. 2019;20:3787.","journal-title":"Int J Mol Sci"},{"key":"1873_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13046-023-02805-y","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, et al. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. J Exp Clin Cancer Res. 2023;42:225.","journal-title":"J Exp Clin Cancer Res"},{"key":"1873_CR46","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.apsb.2024.01.006","volume":"14","author":"C Cheng","year":"2024","unstructured":"Cheng C, Yao H, Li H, Liu J, Liu Z, Wu Y, et al. Blockade of the deubiquitinating enzyme USP48 degrades oncogenic HMGA2 and inhibits colorectal cancer invasion and metastasis. Acta Pharm Sin B. 2024;14:1624\u201343.","journal-title":"Acta Pharm Sin B"},{"key":"1873_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216836","volume":"589","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Li H, Zhang Y, Zhao E, Huang C, Pan X, et al. Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer. Cancer Lett. 2024;589:216836.","journal-title":"Cancer Lett"},{"key":"1873_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05915-9","volume":"14","author":"J Duan","year":"2023","unstructured":"Duan J, Huang D, Liu C, Lv Y, Zhang L, Chang F, et al. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1. Cell Death Dis. 2023;14:402.","journal-title":"Cell Death Dis"},{"key":"1873_CR49","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/s41388-024-03009-0","volume":"43","author":"Q Wu","year":"2024","unstructured":"Wu Q, Wang Z, Chen S, She X, Zhu S, Li P, et al. USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy. Oncogene. 2024;43:1581\u201393.","journal-title":"Oncogene"},{"key":"1873_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03066-4","volume":"21","author":"X Lu","year":"2023","unstructured":"Lu X, Liu R, Liao Y, Cui L, Sun H, Zhang D, et al. ACVRL1 drives resistance to multitarget tyrosine kinase inhibitors in colorectal cancer by promoting USP15-mediated GPX2 stabilization. BMC Med. 2023;21:366.","journal-title":"BMC Med"},{"key":"1873_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00538-x","volume":"13","author":"K Kubaichuk","year":"2024","unstructured":"Kubaichuk K, Seitz T, Bergmann U, Glumoff V, Mennerich D, Kietzmann T. Ubiquitin-specific protease 10 determines colorectal cancer outcome by modulating epidermal growth factor signaling via inositol polyphosphate-4-phosphatase type IIB. Oncogenesis. 2024;13:37.","journal-title":"Oncogenesis"},{"key":"1873_CR52","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1038\/s41388-024-03178-y","volume":"43","author":"H Xu","year":"2024","unstructured":"Xu H, Wang T, Nie H, Sun Q, Jin C, Yang S, et al. USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28. Oncogene. 2024;43:3442\u201355.","journal-title":"Oncogene"},{"key":"1873_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307899","volume":"11","author":"X Guan","year":"2024","unstructured":"Guan X, Wang Y, Yu W, Wei Y, Lu Y, Dai E, et al. Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting stearoyl-CoA desaturase. Adv Sci. 2024;11:e2307899.","journal-title":"Adv Sci"},{"key":"1873_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, et al. USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci USA. 2024;121:e2315541121.","journal-title":"Proc Natl Acad Sci"},{"key":"1873_CR55","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1038\/s41388-018-0342-9","volume":"37","author":"Y Kim","year":"2018","unstructured":"Kim Y, Shiba-Ishii A, Nakagawa T, Iemura SI, Natsume T, Nakano N, et al. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma. Oncogene. 2018;37:5387\u2013402.","journal-title":"Oncogene"},{"key":"1873_CR56","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202306013","volume":"223","author":"A Endo","year":"2024","unstructured":"Endo A, Fukushima T, Takahashi C, Tsuchiya H, Ohtake F, Ono S, et al. USP8 prevents aberrant NF-\u03baB and Nrf2 activation by counteracting ubiquitin signals from endosomes. J Cell Biol. 2024;223:e202306013.","journal-title":"J Cell Biol"},{"key":"1873_CR57","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15548627.2015.1009794","volume":"11","author":"TM Durcan","year":"2015","unstructured":"Durcan TM, Fon EA. USP8 and PARK2\/parkin-mediated mitophagy. Autophagy. 2015;11:428\u20139.","journal-title":"Autophagy"},{"key":"1873_CR58","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1194\/jlr.RA120000760","volume":"61","author":"C Key","year":"2020","unstructured":"Key C, Bishop A, Wang X, Zhao Q, Chen GY, Quinn MA, et al. Human GDPD3 overexpression promotes liver steatosis by increasing lysophosphatidic acid production and fatty acid uptake. J Lipid Res. 2020;61:1075\u201386.","journal-title":"J Lipid Res"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01873-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01873-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:52:55Z","timestamp":1789631575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01873-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01873-y","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}